Ajanta Pharma Limited (BOM:532331)

Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 315.12 billion. The enterprise value is 308.17 billion.

Market Cap	315.12B
Enterprise Value	308.17B

Important Dates

The last earnings date was Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	Nov 10, 2025

Share Statistics

Current Share Class	124.89M
Shares Outstanding	n/a
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	42.34%
Owned by Institutions (%)	20.45%
Float	41.84M

Valuation Ratios

The trailing PE ratio is 32.36 and the forward PE ratio is 27.76.

PE Ratio	32.36
Forward PE	27.76
PS Ratio	6.34
PB Ratio	7.30
P/TBV Ratio	7.37
P/FCF Ratio	97.54
P/OCF Ratio	47.41
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.82, with an EV/FCF ratio of 95.39.

EV / Earnings	31.65
EV / Sales	6.20
EV / EBITDA	22.82
EV / EBIT	25.71
EV / FCF	95.39

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.06.

Current Ratio	2.93
Quick Ratio	2.06
Debt / Equity	0.06
Debt / EBITDA	0.18
Debt / FCF	0.76
Interest Coverage	52.97

Financial Efficiency

Return on equity (ROE) is 24.37% and return on invested capital (ROIC) is 18.12%.

Return on Equity (ROE)	24.37%
Return on Assets (ROA)	14.32%
Return on Invested Capital (ROIC)	18.12%
Return on Capital Employed (ROCE)	26.56%
Revenue Per Employee	5.17M
Profits Per Employee	1.01M
Employee Count	9,628
Asset Turnover	0.95
Inventory Turnover	1.46

Taxes

In the past 12 months, Ajanta Pharma has paid 2.75 billion in taxes.

Income Tax	2.75B
Effective Tax Rate	22.03%

Stock Price Statistics

The stock price has decreased by -9.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-9.67%
50-Day Moving Average	2,495.64
200-Day Moving Average	2,592.68
Relative Strength Index (RSI)	52.80
Average Volume (20 Days)	2,972

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 49.73 billion and earned 9.74 billion in profits. Earnings per share was 77.93.

Revenue	49.73B
Gross Profit	37.67B
Operating Income	11.99B
Pretax Income	12.49B
Net Income	9.74B
EBITDA	13.38B
EBIT	11.99B
Earnings Per Share (EPS)	77.93

Balance Sheet

The company has 9.40 billion in cash and 2.46 billion in debt, giving a net cash position of 6.94 billion.

Cash & Cash Equivalents	9.40B
Total Debt	2.46B
Net Cash	6.94B
Net Cash Per Share	n/a
Equity (Book Value)	43.15B
Book Value Per Share	345.45
Working Capital	22.34B

Cash Flow

In the last 12 months, operating cash flow was 6.65 billion and capital expenditures -3.42 billion, giving a free cash flow of 3.23 billion.

Operating Cash Flow	6.65B
Capital Expenditures	-3.42B
Free Cash Flow	3.23B
FCF Per Share	n/a

Margins

Gross margin is 75.75%, with operating and profit margins of 24.10% and 19.58%.

Gross Margin	75.75%
Operating Margin	24.10%
Pretax Margin	25.11%
Profit Margin	19.58%
EBITDA Margin	26.91%
EBIT Margin	24.10%
FCF Margin	6.50%

Dividends & Yields

This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 1.09%.

Dividend Per Share	28.00
Dividend Yield	1.09%
Dividend Growth (YoY)	-48.15%
Years of Dividend Growth	3
Payout Ratio	35.88%
Buyback Yield	0.61%
Shareholder Yield	1.70%
Earnings Yield	3.09%
FCF Yield	1.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	4